Incomplete Revascularization in the Long Term

Original Title: Long-Term Outcome of Incomplete Revascularization after Percutaneous Coronary Intervention in SCAAR (Swedish Coronary Angiography and Angioplasty Registry). Reference: Kristina Hambraeus et al. J Am Coll Cardiol Intv. 2016;9(3):207-215.

 

The aim of this study was to describe the evolution of patients with multivessel disease undergoing PCI with incomplete revascularization, and its probable association to death, repeat revascularization and MI in the long term.

Between 2006 and 2010 23342 patients with multivessel disease were identified in the SCAAR registry (Swedish Coronary Angiography and Angioplasty Registry). Incomplete revascularization was defined as any vessel with a lesion larger than 60% irrigating at least 10% of the myocardium.

Patients with incomplete revascularization (n = 15,165) were older, with more extensive coronary disease and often had STEMI at presentation, compared to those with complete revascularization (n = 8,177).

At one year, all cause mortality, AMI and repeat revascularization rates were higher among the incomplete revascularization patients, compared to those with complete revascularization (7.1% vs 3.8%, 10.4% vs 6.0% and 20.5% vs 8.5%, respectively).

After propensity score matching, the adjusted risk at one year for the composite of death, MI or revascularization was significantly higher for the incomplete revascularization group. (HR 2.12 CI 95% 1.98 to 2.28; p < 0.0001).

The adjusted risk of death and the combination of death/MI also resulted higher for the incomplete revascularization group with 1.29 (CI 95% 1.12 to 1.49; p=0.0005) and 1.42 (CI 95% 1.30 to 1.56; p<0.0001), respectively.

Conclusion
Incomplete revascularization at discharge in patients with multivessel disease undergoing PCI is associated with a high risk of adverse cardiac events at one year.

Editorial Comment
So far, the evidence is conflictive and generally indirect. Even though this study provides important data, is limited by its retrospective character and by the fact that it was carried out in different populations, which required several adjustments for researchers to be able to compare. Clearly, in almost all studies, patients with incomplete revascularization are always at higher risk, and their treatment was determined by the impossibility to receive a complete revascularization, rather than by choice.

More articles by this author

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

TCT 2024 | Use of Drug-Coated Balloons for Side Branch Treatment in Provisional Stenting

In some cases, treating coronary bifurcations with provisional stenting requires side branch stenting, which may lead to suboptimal outcomes. Drug-coated balloons (DCBs) have emerged...

TCT 2024 | Use of Artificial Intelligence for Patients with Suspected Coronary Artery Disease

The current approach to chest pain mainly focuses on symptom characteristics, conducting functional tests for ischemia assessment. However, several randomized clinical trials have shown...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 | TRISCEND II

This randomized study included 400 patients; 267 were treated with EVOQUE valve and 133 with optimal medical treatment (OMT). After one-year follow-up, there were no...

TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods.  Based on the CHOICE-CLOSURE and MASH...